☰

Susan E. Conrad - Publications

Affiliations: 
Michigan State University, East Lansing, MI 
Area:
Biochemistry, Cell Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Misek SA, Foda BM, Dexheimer TS, Akram M, Conrad SE, Schmidt JC, Neubig RR, Gallo KA. BRAF Inhibitor Resistance Confers Increased Sensitivity to Mitotic Inhibitors. Frontiers in Oncology. 12: 766794. PMID 35444937 DOI: 10.3389/fonc.2022.766794  0.316
2019 Gallo KA, Ellsworth E, Stoub H, Conrad SE. Therapeutic potential of targeting mixed lineage kinases in cancer and inflammation. Pharmacology & Therapeutics. 107457. PMID 31863814 DOI: 10.1016/J.Pharmthera.2019.107457  0.408
2018 Ibrahim SAE, Abudu A, Jonhson E, Aftab N, Conrad S, Fluck M. The role of AP-1 in self-sufficient proliferation and migration of cancer cells and its potential impact on an autocrine/paracrine loop. Oncotarget. 9: 34259-34278. PMID 30344941 DOI: 10.18632/Oncotarget.26047  0.515
2017 Rattanasinchai C, Llewellyn BJ, Conrad SE, Gallo KA. MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells. Oncogenesis. 6: e345. PMID 28604765 DOI: 10.1038/oncsis.2017.44  0.363
2017 Rattanasinchai C, Llewellyn B, Conrad SE, Gallo KA. Abstract 2374: Mixed-Lineage Kinase 3 signals through the FRA1-MMP1 axis to drive triple-negative breast cancer invasion and transendothelial migration Cancer Research. 77: 2374-2374. DOI: 10.1158/1538-7445.Am2017-2374  0.44
2013 Wang L, Gallo KA, Conrad SE. Targeting mixed lineage kinases in ER-positive breast cancer cells leads to G2/M cell cycle arrest and apoptosis. Oncotarget. 4: 1158-71. PMID 23902710 DOI: 10.18632/Oncotarget.1093  0.573
2012 Marina M, Wang L, Conrad SE. The scaffold protein MEK Partner 1 is required for the survival of estrogen receptor positive breast cancer cells. Cell Communication and Signaling : Ccs. 10: 18. PMID 22776333 DOI: 10.1186/1478-811X-10-18  0.704
2012 Wang L, Gallo K, Conrad SE. Abstract 2807: Inhibition of mixed lineage kinase activity results in G2/M arrest and apoptosis in ER-positive breast cancer cells Cancer Research. 72: 2807-2807. DOI: 10.1158/1538-7445.Am2012-2807  0.611
2010 Santos SJ, Haslam SZ, Conrad SE. Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse. Endocrinology. 151: 2876-85. PMID 20392833 DOI: 10.1210/En.2009-1282  0.729
2009 Santos SJ, Aupperlee MD, Xie J, Durairaj S, Miksicek R, Conrad SE, Leipprandt JR, Tan YS, Schwartz RC, Haslam SZ. Progesterone receptor A-regulated gene expression in mammary organoid cultures. The Journal of Steroid Biochemistry and Molecular Biology. 115: 161-72. PMID 19383543 DOI: 10.1016/J.Jsbmb.2009.04.001  0.695
2008 Santos SJ, Haslam SZ, Conrad SE. Estrogen and progesterone are critical regulators of Stat5a expression in the mouse mammary gland. Endocrinology. 149: 329-38. PMID 17884938 DOI: 10.1210/En.2007-0594  0.726
2007 Varma H, Skildum AJ, Conrad SE. Functional ablation of pRb activates Cdk2 and causes antiestrogen resistance in human breast cancer cells. Plos One. 2: e1256. PMID 18060053 DOI: 10.1371/Journal.Pone.0001256  0.745
2005 Mukherjee S, Conrad SE. c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells. The Journal of Biological Chemistry. 280: 17617-25. PMID 15757889 DOI: 10.1074/Jbc.M502278200  0.669
2004 Tang YP, Haslam SZ, Conrad SE, Sisk CL. Estrogen increases brain expression of the mRNA encoding transthyretin, an amyloid beta scavenger protein. Journal of Alzheimer's Disease : Jad. 6: 413-20; discussion 4. PMID 15345812 DOI: 10.3233/Jad-2004-6409  0.325
2004 Han F, Miksicek R, Clarke R, Conrad SE. Expression of an estrogen receptor variant lacking exon 3 in derivatives of MCF-7 cells with acquired estrogen independence or tamoxifen resistance. Journal of Molecular Endocrinology. 32: 935-45. PMID 15171723 DOI: 10.1677/Jme.0.0320935  0.571
2004 Zhang H, Wu W, Du Y, Santos SJ, Conrad SE, Watson JT, Grammatikakis N, Gallo KA. Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling. The Journal of Biological Chemistry. 279: 19457-63. PMID 15001580 DOI: 10.1074/Jbc.M311377200  0.727
2002 Varma H, Conrad SE. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling. Cancer Research. 62: 3985-91. PMID 12124331  0.625
2002 Skildum AJ, Mukherjee S, Conrad SE. The cyclin-dependent kinase inhibitor p21WAF1/Cip1 is an antiestrogen-regulated inhibitor of Cdk4 in human breast cancer cells. The Journal of Biological Chemistry. 277: 5145-52. PMID 11741909 DOI: 10.1074/Jbc.M109179200  0.751
2000 Varma H, Conrad SE. Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain. Oncogene. 19: 4746-53. PMID 11032025 DOI: 10.1038/Sj.Onc.1203827  0.67
1996 Anderson MM, Chen J, Cole CN, Conrad SE. Activation of the human thymidine kinase (TK) promoter by simian virus 40 large T antigen requires both the T antigen pRb family-binding domain and TK promoter sequences resembling E2F-binding sites Journal of Virology. 70: 6304-6313. PMID 8709258 DOI: 10.1128/Jvi.70.9.6304-6313.1996  0.347
1994 Carozza MA, Conrad SE. Regulation of thymidine kinase protein stability in serum-stimulated cells Cell Growth and Differentiation. 5: 901-908. PMID 7986755  0.311
1993 Roehl HH, Anderson MM, Mehigh CS, Conrad SE. Regulation of the cellular thymidine kinase gene promoter in simian virus 40-infected cells Journal of Virology. 67: 4964-4971. PMID 8392622 DOI: 10.1128/Jvi.67.8.4964-4971.1993  0.436
1992 Dagher SF, Conrad SE, Werner EA, Patterson RJ. Phenotypic conversion of TK-deficient cells following electroporation of functional TK enzyme. Experimental Cell Research. 198: 36-42. PMID 1727056 DOI: 10.1016/0014-4827(92)90146-Y  0.383
1990 Roehl HH, Conrad SE. Identification of a G1-S-Phase-Regulated Region in the Human Thymidine Kinase Gene Promoter Molecular and Cellular Biology. 10: 3834-3837. PMID 2355925 DOI: 10.1128/Mcb.10.7.3834  0.391
1987 Stewart CJ, Ito M, Conrad SE. Evidence for transcriptional and post-transcriptional control of the cellular thymidine kinase gene Molecular and Cellular Biology. 7: 1156-1163. PMID 3561412 DOI: 10.1128/Mcb.7.3.1156  0.474
1985 Stuart P, Ito M, Stewart C, Conrad SE. Induction of cellular thymidine kinase occurs at the mRNA level Molecular and Cellular Biology. 5: 1490-1497. PMID 2993867 DOI: 10.1128/Mcb.5.6.1490  0.382
1982 Conrad SE, Liu CP, Botchan MR. Fragment spanning the SV40 replication origin is the only DNA sequence required in cis for viral excision. Science (New York, N.Y.). 218: 1223-5. PMID 6293055 DOI: 10.1126/Science.6293055  0.419
1979 Conrad SE, Campbell JL. Characterization of an improved in vitro DNA replication system for Escherichia coli plasmids Nucleic Acids Research. 6: 3289-3304. PMID 384367 DOI: 10.1093/Nar/6.10.3289  0.315
Show low-probability matches.